These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27213264)

  • 21. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
    Knowles K; Lorange M; Matthews RC; Preston NW
    Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis in the Era of New Strains of Bordetella pertussis.
    Souder E; Long SS
    Infect Dis Clin North Am; 2015 Dec; 29(4):699-713. PubMed ID: 26337739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis infection and vaccination induces Th1 cells.
    Brady MT; Mahon BP; Mills KH
    Immunol Today; 1998 Nov; 19(11):534. PubMed ID: 9818551
    [No Abstract]   [Full Text] [Related]  

  • 26. The advent of recombinant pertussis vaccines.
    Burnette WN
    Biotechnology (N Y); 1990 Nov; 8(11):1002-5. PubMed ID: 1366927
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?].
    Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 30. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome characteristics of
    Ben Fraj I; Bouchez V; Smaoui H; Kechrid A; Brisse S
    J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative genomics of whole-cell pertussis vaccine strains from India.
    Alai S; Ghattargi VC; Gautam M; Patel K; Pawar SP; Dhotre DP; Shaligram U; Gairola S
    BMC Genomics; 2020 May; 21(1):345. PubMed ID: 32381023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
    Bart MJ; Harris SR; Advani A; Arakawa Y; Bottero D; Bouchez V; Cassiday PK; Chiang CS; Dalby T; Fry NK; Gaillard ME; van Gent M; Guiso N; Hallander HO; Harvill ET; He Q; van der Heide HG; Heuvelman K; Hozbor DF; Kamachi K; Karataev GI; Lan R; Lutyńska A; Maharjan RP; Mertsola J; Miyamura T; Octavia S; Preston A; Quail MA; Sintchenko V; Stefanelli P; Tondella ML; Tsang RS; Xu Y; Yao SM; Zhang S; Parkhill J; Mooi FR
    mBio; 2014 Apr; 5(2):e01074. PubMed ID: 24757216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010.
    Petersen RF; Dalby T; Dragsted DM; Mooi F; Lambertsen L
    Emerg Infect Dis; 2012 May; 18(5):767-74. PubMed ID: 22515990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.
    Litt DJ; Neal SE; Fry NK
    J Clin Microbiol; 2009 Mar; 47(3):680-8. PubMed ID: 19158267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.
    Peppler MS; Kuny S; Nevesinjac A; Rogers C; de Moissac YR; Knowles K; Lorange M; De Serres G; Talbot J
    J Clin Microbiol; 2003 Jul; 41(7):3344-7. PubMed ID: 12843089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.